US BIOTECH STARS

The portfolio invests in small to medium Biotech companies listed on the NASDAQ (US or foreign companies), with a view to maximize growth on 5 years horizon. Occasionally, the portfolio may be invested for a small portion (less than 10%) on other US stocks or ETFs. Short selling may be possible, although not the preferred strategy Trading ideas are generated first by technical analysis, using a proprietary model. The results are then scanned an combined with fundamental research information Portfolio replicates higher weightings constituents of the XBI tracker, and also includes some individuals stocks based on technical anaylisis and conviction. Objective is to beat the XBI performance. The holding period may vary from a few days to several months